AGENUS INC - 24 Aug 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
10%+ Owner
Signature
/s/ Christine Klaskin, Vice President, Finance
Issuer symbol
INKT
Transactions as of
24 Aug 2023
Transactions value $
$281,478
Form type
4
Filing time
28 Aug 2023, 18:15:39 UTC
Previous filing
12 May 2023
Next filing
31 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Purchase $262,908 +170,244 +0.79% $1.54 21,692,401 24 Aug 2023 Direct F1, F2
transaction INKT Common Stock Purchase $18,570 +12,808 +0.06% $1.45 21,705,209 28 Aug 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market purchases reported on this line occurred at a weighted average price of $1.5443 (range of $1.52 to $1.55).
F2 Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
F3 Open market purchases reported on this line occurred at a weighted average price of $1.4499 (range of $1.44 to $1.45).